Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural biology of SARS-CoV-2 Mpro and drug discovery
Yinkai Duan, Haofeng Wang, Zhenghong Yuan, et al.
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102667-102667
Closed Access | Times Cited: 23

Showing 23 citing articles:

Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 11
Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease
Takashi Miura, Tika R. Malla, Lennart Brewitz, et al.
Bulletin of the Chemical Society of Japan (2024) Vol. 97, Iss. 5
Open Access | Times Cited: 11
On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 17
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials
Vitor Martins de Freitas Amorim, Eduardo Pereira Soares, Anielle Salviano de Almeida Ferrari, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 844-844
Open Access | Times Cited: 5
Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation
Sanadelaslam S. A. El‐Hddad, Mohamed Hossam Sobhy, Ahmed El‐Morsy, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13237-13250
Open Access | Times Cited: 4
In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations
Takeshi Ishikawa, Kenji Matsumoto, Toshiyuki Hamada, et al.
The Journal of Physical Chemistry B (2025) Vol. 129, Iss. 6, pp. 1740-1749
Closed Access
Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation
Gayatri Tehlan, Lennart Brewitz, Lewis T. Ibbotson, et al.
Chemical Science (2024) Vol. 15, Iss. 20, pp. 7667-7678
Open Access | Times Cited: 3
Rational design and synthesis of pyrazole derivatives as potential SARS-CoV-2 Mpro inhibitors: An integrated approach merging combinatorial chemistry, molecular docking, and deep learning
Arthur Antunes Ferrarezi, João Vítor Perez de Souza, Bernard Maigret, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118095-118095
Closed Access
The Dynamical Asymmetry in SARS-CoV2 Protease Reveals the Exchange Between Catalytic Activity and Stability in Homodimers
Velia Minicozzi, Alessandro Giuliani, Giampiero Mei, et al.
Molecules (2025) Vol. 30, Iss. 7, pp. 1412-1412
Open Access
3-Chymotrypsin-like Protease (3CLpro): Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials
Vitor Martins de Freitas Amorim, Eduardo Pereira Soares, Anielle Salviano de Almeida Ferrari, et al.
(2024)
Open Access | Times Cited: 2
Fixing the Achilles Heel of Pfizer’s Paxlovid for COVID-19 Treatment
Lennart Brewitz, Christopher J. Schofield
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11656-11661
Open Access | Times Cited: 2
Crystallographic Data Collection Using a Multilayer Monochromator on an Undulator Beamline at the Shanghai Synchrotron Radiation Facility
Chenyu Zhang, Xu Qin, Weiwei Wang, et al.
Crystals (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 1
Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivatives
Blake M. Shellenberger, Olivia N. Basile, Joel Cassel, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 102, pp. 129679-129679
Closed Access | Times Cited: 1
High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro
Feng Wang, Tiancheng Ma, Donglan Liu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning
Mingyang Wang, Shuai Li, Jike Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups
Qiao Huang, Baoxue Quan, Yan Chen, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107001-107001
Closed Access | Times Cited: 3
Structural Basis for the Inhibition of Coronaviral Main Proteases by Pf-00835231
Xuelan Zhou, xiaolu lu, Jian Li, et al.
(2023)
Open Access | Times Cited: 2
Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Xuelan Zhou, Xiaolu Lu, Cheng‐Wen Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Marine Origin vs. Synthesized Compounds: In Silico Screening for a Potential Drug Against SARS-CoV-2
Amar Osmanović, Mirsada Salihović, Elma Veljović, et al.
Scientia Pharmaceutica (2024) Vol. 93, Iss. 1, pp. 2-2
Open Access
Generative Adversarial Network (Gan) Model-Based Design of Potent Sars-Cov-2 Mpro Inhibitors Using the Electron Density of Ligands and 3d Binding Pockets: Insights from Molecular Docking, Dynamics Simulation, and Mm-Gbsa Analysis
Annesha Chakraborty, Vignesh Krishnan, Subbiah Thamotharan
(2024)
Closed Access
Structural basis for the inhibition of coronaviral main proteases by PF-00835231
Xuelan Zhou, Xiaolu Lu, Cheng‐Wen Lin, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Generative adversarial network (GAN) model-based design of potent SARS-CoV-2 Mpro inhibitors using the electron density of ligands and 3D binding pockets: insights from molecular docking, dynamics simulation, and MM-GBSA analysis
Annesha Chakraborty, Vignesh Krishnan, Subbiah Thamotharan
Molecular Diversity (2024)
Closed Access
Study of the Interaction of the S-Protein of SARS-CoV-2 with Isolated Lipid Model Membranes
V. R. Samygina, Anna V. Vlaskina, Evgeny Pichkur, et al.
Crystallography Reports (2024) Vol. 69, Iss. 6, pp. 931-938
Closed Access
Page 1

Scroll to top